Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-Ketamine for Pain After Total Knee Arthroplasty
NCT05289050Phase 4Unknown
- Sponsor
- Lingdong Biotech
- Start
- Apr 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in postoperative pain, sponsored by Lingdong Biotech. Status: unknown.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05289050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05289050.